340 related articles for article (PubMed ID: 16431074)
1. The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment.
Kim R; Emi M; Tanabe K; Uchida Y; Arihiro K
Eur J Surg Oncol; 2006 Apr; 32(3):269-77. PubMed ID: 16431074
[TBL] [Abstract][Full Text] [Related]
2. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.
Aoki H; Takada Y; Kondo S; Sawaya R; Aggarwal BB; Kondo Y
Mol Pharmacol; 2007 Jul; 72(1):29-39. PubMed ID: 17395690
[TBL] [Abstract][Full Text] [Related]
3. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
Moretti L; Yang ES; Kim KW; Lu B
Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
[TBL] [Abstract][Full Text] [Related]
4. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells.
Gossner G; Choi M; Tan L; Fogoros S; Griffith KA; Kuenker M; Liu JR
Gynecol Oncol; 2007 Apr; 105(1):23-30. PubMed ID: 17234261
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
6. Modulation of apoptotic pathways triggered by cytotoxic agents.
Solary E; Plenchette S; Sordet O; Rébé C; Ducoroy P; Filomenko R; Bruey JM; Droin N; Corcos L
Therapie; 2001; 56(5):511-8. PubMed ID: 11806287
[TBL] [Abstract][Full Text] [Related]
7. The death of human cancer cells following photodynamic therapy: apoptosis competence is necessary for Bcl-2 protection but not for induction of autophagy.
Xue LY; Chiu SM; Azizuddin K; Joseph S; Oleinick NL
Photochem Photobiol; 2007; 83(5):1016-23. PubMed ID: 17880494
[TBL] [Abstract][Full Text] [Related]
8. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
[TBL] [Abstract][Full Text] [Related]
9. Akt induces apoptosis in neuroblastoma cells expressing a C98X vasopressin mutant following autophagy suppression.
Castino R; Thepparit C; Bellio N; Murphy D; Isidoro C
J Neuroendocrinol; 2008 Oct; 20(10):1165-75. PubMed ID: 18673414
[TBL] [Abstract][Full Text] [Related]
10. Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model.
Hersey P; Zhuang L; Zhang XD
Int Rev Cytol; 2006; 251():131-58. PubMed ID: 16939779
[TBL] [Abstract][Full Text] [Related]
11. Improving the selectivity of cancer treatments by interfering with cell response pathways.
Damia G; Broggini M
Eur J Cancer; 2004 Nov; 40(17):2550-9. PubMed ID: 15541958
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding the cell death pathways activated by anticancer therapy.
Kim R
Cancer; 2005 Apr; 103(8):1551-60. PubMed ID: 15742333
[TBL] [Abstract][Full Text] [Related]
13. Autophagy in cancer and chemotherapy.
Yousefi S; Simon HU
Results Probl Cell Differ; 2009; 49():183-90. PubMed ID: 19142622
[TBL] [Abstract][Full Text] [Related]
14. Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells.
Moon DO; Park SY; Choi YH; Kim ND; Lee C; Kim GY
Toxicon; 2008 Jan; 51(1):112-20. PubMed ID: 17936321
[TBL] [Abstract][Full Text] [Related]
15. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
16. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of cFLIPs inhibits oxaliplatin-mediated apoptosis through enhanced XIAP stability and Akt activation in human renal cancer cells.
Kim S; Lee TJ; Park JW; Kwon TK
J Cell Biochem; 2008 Nov; 105(4):971-9. PubMed ID: 18767116
[TBL] [Abstract][Full Text] [Related]
18. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
Yang X; Fraser M; Moll UM; Basak A; Tsang BK
Cancer Res; 2006 Mar; 66(6):3126-36. PubMed ID: 16540663
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 family proteins and cancer.
Yip KW; Reed JC
Oncogene; 2008 Oct; 27(50):6398-406. PubMed ID: 18955968
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells.
Zhang LJ; Hao YZ; Hu CS; Ye Y; Xie QP; Thorne RF; Hersey P; Zhang XD
Anticancer Drugs; 2008 Feb; 19(2):159-66. PubMed ID: 18176112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
